» Articles » PMID: 30864286

Early-onset Triple-negative Breast Cancer in Multiracial/ethnic Populations: Distinct Trends of Prevalence of Truncation Mutations

Overview
Journal Cancer Med
Specialty Oncology
Date 2019 Mar 14
PMID 30864286
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Young black women are at higher risk of triple-negative breast cancer (TNBC); however, a majority of the genetic studies on cancer predisposition were carried out in White populations. The underrepresentation of minority racial/ethnic populations in cancer genetic studies may have led to disproportionate gaps in our knowledge of cancer predisposition genes in these populations. We surveyed the protein-truncating mutations at the exome-wide scale and in known breast cancer predisposition genes among 170 patients of multiple racial/ethnic groups with early-onset (≤age 50) TNBC from two independent cohorts. Black patients, on average, had a higher number of truncating mutations than Whites at the exome-wide level, but fewer truncating mutations in the panel of known breast cancer genes. White TNBC patients showed a strong enrichment of truncating variants in known breast cancer genes, whereas no such enrichment was found among Black patients. Our findings indicate likely more breast cancer disposition genes yet to be discovered in minority racial/ethnic groups, and the current multigene panels may result in unequal benefits from cancer genetic testing.

Citing Articles

Reproductive Considerations for Patients with Early-Onset Breast Cancer.

Pleasant V, Ulrich N, Pearlman M, Moravek M Curr Breast Cancer Rep. 2024; 14(2):37-45.

PMID: 39525552 PMC: 11548833. DOI: 10.1007/s12609-022-00445-3.


Patient counseling for breast cancer screening: Taking changes to USPSTF recommendations into account.

Pleasant V OBG Manag. 2024; 35(12):43-49.

PMID: 38835939 PMC: 11148851. DOI: 10.12788/obgm.0334.


DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review.

Urbina-Jara L, Martinez-Ledesma E, Rojas-Martinez A, Rodriguez-Recio F, Ortiz-Lopez R Int J Mol Sci. 2021; 22(23).

PMID: 34884835 PMC: 8657579. DOI: 10.3390/ijms222313030.


Distinct Somatic Alteration Features Identified by Gene Panel Sequencing in Korean Triple-Negative Breast Cancer with High Ki67 Expression.

Sun W, Lee J, Kim B, Kim J, Park J Diagnostics (Basel). 2021; 11(3).

PMID: 33804295 PMC: 8000916. DOI: 10.3390/diagnostics11030416.


Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.

Urbina-Jara L, Rojas-Martinez A, Martinez-Ledesma E, Aguilar D, Villarreal-Garza C, Ortiz-Lopez R Genes (Basel). 2019; 10(10).

PMID: 31658756 PMC: 6827033. DOI: 10.3390/genes10100786.


References
1.
Hall M, Olopade O . Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol. 2006; 24(14):2197-203. DOI: 10.1200/JCO.2006.05.5889. View

2.
Lu C, Xie M, Wendl M, Wang J, McLellan M, Leiserson M . Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 2015; 6:10086. PMC: 4703835. DOI: 10.1038/ncomms10086. View

3.
Shimelis H, LaDuca H, Hu C, Hart S, Na J, Thomas A . Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J Natl Cancer Inst. 2018; 110(8):855-862. PMC: 6093350. DOI: 10.1093/jnci/djy106. View

4.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

5.
Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View